IRIS
BERARDICURTI, ONORINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.062
NA - Nord America 2.584
EU - Europa 956
SA - Sud America 392
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 52
OC - Oceania 6
Totale 8.125
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.497
US - Stati Uniti d'America 2.482
CN - Cina 705
IT - Italia 459
HK - Hong Kong 386
BR - Brasile 291
VN - Vietnam 164
GB - Regno Unito 115
FR - Francia 113
BD - Bangladesh 100
DE - Germania 88
IN - India 54
CA - Canada 50
NL - Olanda 35
AR - Argentina 34
ID - Indonesia 30
MX - Messico 28
ES - Italia 24
TR - Turchia 21
ZA - Sudafrica 21
JP - Giappone 20
EC - Ecuador 18
CO - Colombia 16
FI - Finlandia 16
UA - Ucraina 15
IQ - Iraq 13
PL - Polonia 12
MA - Marocco 11
SA - Arabia Saudita 11
CL - Cile 10
CZ - Repubblica Ceca 9
PY - Paraguay 9
RU - Federazione Russa 9
AT - Austria 7
MD - Moldavia 7
PH - Filippine 7
PK - Pakistan 7
AU - Australia 6
BG - Bulgaria 6
IE - Irlanda 6
JM - Giamaica 6
PE - Perù 6
SE - Svezia 6
VE - Venezuela 6
IL - Israele 5
LT - Lituania 5
TN - Tunisia 5
DZ - Algeria 4
NP - Nepal 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EE - Estonia 3
JO - Giordania 3
LB - Libano 3
LV - Lettonia 3
RS - Serbia 3
SV - El Salvador 3
AL - Albania 2
BE - Belgio 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
TL - Timor Orientale 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MG - Madagascar 1
MM - Myanmar 1
NG - Nigeria 1
Totale 8.047
Salva come PNG Salva come JPEG
Città #
San Jose 620
Ashburn 528
Singapore 426
Hong Kong 383
Rome 256
Beijing 232
Hefei 203
Council Bluffs 186
Columbus 112
Boardman 110
Dallas 102
Lauterbourg 92
London 84
Santa Clara 70
Ho Chi Minh City 69
Shanghai 62
New York 49
Phoenix 44
Munich 33
Hanoi 28
Los Angeles 27
Amsterdam 26
Naples 24
São Paulo 24
Denver 22
San Francisco 22
Mexico City 19
Washington 19
Toronto 18
Bari 16
Pune 16
Frankfurt am Main 15
Tokyo 14
Atlanta 12
Brooklyn 12
Milan 12
Buffalo 11
Seattle 11
Warsaw 11
Chicago 10
Haiphong 10
Las Vegas 9
Montreal 9
Nuremberg 9
Ankara 8
Guayaquil 8
Jaguariúna 8
Turku 8
West Jordan 8
Boston 7
Brasília 7
Jinan 7
Johannesburg 7
Porto Alegre 7
Baghdad 6
Brno 6
Chennai 6
Da Nang 6
Helsinki 6
Hải Dương 6
Manchester 6
Belo Horizonte 5
Curitiba 5
Dublin 5
Guangzhou 5
Madrid 5
Stockholm 5
Biên Hòa 4
Can Tho 4
Cape Town 4
Champlin 4
Dammam 4
Guarulhos 4
Istanbul 4
Medellín 4
Noicattaro 4
Orem 4
Pescara 4
Pittsburgh 4
Rio de Janeiro 4
Riyadh 4
Shijiazhuang 4
Sofia 4
State College 4
Sydney 4
Americana 3
Andradina 3
Augusta 3
Bauru 3
Bogotá 3
Bologna 3
Buenos Aires 3
Bắc Giang 3
Campinas 3
Changsha 3
Chapecó 3
Cotia 3
Diadema 3
Karachi 3
L’Aquila 3
Totale 4.331
Salva come PNG Salva come JPEG
Nome #
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 241
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 230
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 225
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 209
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 179
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 174
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 134
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 130
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 130
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 125
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 124
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 123
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 121
Cytokine storm syndrome in severe COVID-19 116
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 111
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 110
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 109
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 106
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 103
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 102
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 102
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 102
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 100
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 99
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 96
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndrome 96
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 96
Cardiovascular disease in primary sjögren’s syndrome 94
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 93
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 89
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 89
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 79
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 76
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 76
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 74
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 74
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 73
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 73
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 72
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 72
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 70
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 69
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 68
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 67
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 67
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 66
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 65
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 65
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 65
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 64
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 63
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 61
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 61
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction 61
Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature 60
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 60
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 59
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 58
Vitamin D and systemic lupus erythematosus - The hype and the hope 58
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 58
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 57
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 57
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 55
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 55
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 54
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 54
Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome 54
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 53
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease 53
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry 53
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 53
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 53
Endothelial-to-mesenchymal transition in systemic sclerosis 53
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 53
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist? 52
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm 52
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 52
Interstitial lung disease in systemic sclerosis: current and future treatment. 51
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 50
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 49
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 49
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 49
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 48
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis 47
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 47
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 46
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 46
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 46
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 45
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 45
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 45
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 45
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 44
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 44
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratification 43
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 42
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 42
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 41
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 41
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 39
Totale 7.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 0 0 0 0 0 0 0 18 4 5 82
2022/202398 1 2 2 4 15 1 2 8 3 5 54 1
2023/2024339 16 35 15 40 40 139 7 10 3 13 13 8
2024/20252.948 48 44 117 29 30 72 71 32 252 252 784 1.217
2025/20263.708 345 144 259 432 141 191 974 264 273 347 262 76
2026/2027921 69 281 330 241 0 0 0 0 0 0 0 0
Totale 8.125